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A B S T R A C T
Our understanding of how, and the extent to which, phytopathogens reconfigure host metabolic pathways to
enhance virulence is remarkably limited. Here we investigate the dynamics of the natural disaccharide nu-
cleoside, 3′-O-β-D-ribofuranosyladenosine, in leaves of Arabidopsis thaliana infected with virulent Pseudomonas
syringae pv. tomato strain DC3000. 3′-O-β-D-ribofuranosyladenosine is a plant derived molecule that rapidly
accumulates following delivery of P. syringae type III effectors to represent a major component of the infected
leaf metabolome. We report the first synthesis of 3′-O-β-D-ribofuranosyladenosine using a method involving the
condensation of a small excess of 1-O-acetyl-2,3,5-three-O-benzoyl-β-ribofuranose activated with tin tetra-
chloride with 2′,5′-di-O-tert-butyldimethylsilyladenosine in 1,2-dichloroethane with further removal of silyl and
benzoyl protecting groups. Interestingly, application of synthetic 3′-O-β-D-ribofuranosyladenosine did not affect
either bacterial multiplication or infection dynamics suggesting a major reconfiguration of metabolism during
pathogenesis and a heavy metabolic burden on the infected plant.
1. Introduction
Our understanding of the genetic basis of plant innate immunity has
improved greatly over the past two decades. Biochemically, we un-
derstand the core receptors involved in the two key immunity re-
sponses, the initial MAMP (microbe associated molecular patterns)
triggered immunity (MTI) and subsequent effector triggered immunity
(ETI) where activity of pathogen effectors delivered into the plant cell
are recognized by classical plant disease resistance proteins (Jones and
Dangl, 2006). We are unravelling the basis of suppression of plant
immunity, driven by pathogen effectors (primarily proteins, but also
small molecules), which suppress MTI and ETI to cause disease (effector
triggered suppression, ETS; (Boutrot and Zipfel, 2017; Jones and Dangl,
2006)). While our understanding of the underlying transcriptional re-
programming association with this transition from defense to disease is
becoming clearer (Lewis et al., 2015), our knowledge of the small
molecules deployed to effect this transition is notably limited.
About fifteen years ago an exciting discovery reported that phyto-
pathogenic bacteria such as the Pseudomonadaceae Pseudomonas syr-
ingae, induced the formation of a novel disaccharide nucleoside 3′-O-β-
D-ribofuranosyladenosine in infected leaves (Bednarek et al., 2004).
Subsequently, untargeted approaches validated 3′-O-β-D-ribofur-
anosyladenosine as a key discriminant molecule of a compatible in-
teraction between the model Brassicaceae Arabidopsis thaliana and the
virulent Pseudomonas syringae pv. tomato strain DC3000 (DC3000)
(Ward et al., 2010). 3′-O-β-D-ribofuranosyladenosine (hereafter re-
ferred to as 3′-O-β-D-RFA) is a particularly interesting molecule, not
only for its unique structure, but also because to date most specialised
metabolites associated with Arabidopsis thaliana responses to pathogens
are predominately indolic derivatives. The rapid induction of 3′-O-β-D-
RFA to high levels upon infection in both tomato and A. thaliana pre-
cedes reported increases in indole derivatives (Bednarek et al., 2004;
Ward et al., 2010) and suggests an important role in suppression of
plant immunity.
Disaccharide nucleosides belong to an important group of natural
compounds, forming components of biopolymers, such as poly(ADP-
ribose) and tRNA, which underpin fundamental roles in living organ-
isms (Drenichev & Mikhailov, 2015, 2016; Efimtseva et al., 2009;
Efimtseva and Mikhailov, 2002). These compounds contain an extra
carbohydrate residue linked to one of the nucleoside hydroxyl groups
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via an O-glycosidic bond. The presence of a disaccharide residue and a
heterocyclic base makes their properties similar to those of carbohy-
drates and nucleosides (Drenichev & Mikhailov, 2015, 2016; Efimtseva
et al., 2009; Efimtseva and Mikhailov, 2002). Over one hundred such
compounds and their derivatives have been isolated from various
sources and are implicated in a broad spectrum of biological activities,
including antibacterial, fungicidal, herbicidal, anti-tumour and anti-
viral (Drenichev & Mikhailov, 2015, 2016; Efimtseva et al., 2009;
Efimtseva and Mikhailov, 2002).
There is increasing evidence that ATP, NAD and PARP mediated
ADP-ribosylation play a role in plant immune responses (see (Miwa
et al., 2017; Petriacq et al., 2013) for reviews). Originally described as a
mechanism of DNA break repair, poly(ADP-ribos)ylation has been
linked to transcriptional control of gene expression, regulation of me-
tabolism and dynamic reorganization of chromatin structure. In plants
poly(ADP-ribos)ylation has received surprisingly little attention. It has
been implicated in cycle control, development and response to abiotic
and biotic stress. Mutations in genes encoding poly-ADPribosylases
(parps; (Adams-Phillips et al., 2010; Adams-Phillips et al., 2008; Song
et al., 2015)) or NUDIX ADP-ribose/NADH pyrophosphohydrolases (Ge
et al., 2007; Ishikawa et al., 2010; Jambunathan et al., 2010) affect
basal immunity, whereas production of NAD+ derivatives through
metabolism of quinolate in plants expressing E. coli nadC enhanced
resistance to already strong ETI interactions (Petriacq et al., 2012). The
pyridine nucleotides NAD+ and NADP + play vital roles in metabolic
reactions, either as signal molecules themselves or via their derivatives.
Indeed, they are being increasingly linked to plant immune processes
(see (Miwa et al., 2017; Petriacq et al., 2012) for reviews). Consistent
with this, multiple mutations in aspartate oxidase, the chloroplast lo-
calized primary enzyme of de novo NAD+ synthesis (Katoh et al.,
2006), were identified in a genetic screen for compromised basal im-
munity to DC3000 (Macho et al., 2012). Enhanced resistance was also
shown to be associated with increased pools of intracellular NAD+ in
quinolate treated nadC plants, correlating ETI resistance with enhanced
reactive oxygen species (ROS) which, unlike classical respiratory burst
homologue (RBHO) derived apoplastic ROS, was of mitochondrial
origin (Petriacq et al., 2016).
Taking into account the well-established role of ROS generation in
plant innate immunity (both PTI and ETI), it is entirely feasible to
speculate that effective plant pathogens may deploy strategies to reduce
the pool of pyridine nucleotides as a core part of their ETS mechanism.
Given both the novel and highly interesting compound class, and its
rapid accumulation early in establishment of disease, we further in-
vestigated the role of 3′-O-β-D-RFA in plant-pathogen interactions.
2. Results
2.1. Accumulation of 3′-O-β-D-ribofuranosyladenosine during infection of
plant leaves with Pseudomonas syringae
Using a single reaction monitoring method previously established
using purified 3′-O-β-D-RFA standard (Ward et al., 2010) we monitored
3′-O-β-D-RFA accumulation in leaves following DC3000 infection. 3′-O-
β-D-RFA accumulated remarkably rapidly, within 4 h post infection
(hpi) with DC3000 (OD600 0.15; Fig. S1) and continued to accumulate
exponentially, mirroring the observed bacterial growth measured under
identical conditions (Lewis et al., 2015). The rapid appearance of 3′-O-
β-D-RFA was striking as bacterial effectors are not delivered into the
plant cells until ∼3 hpi after challenge and DC3000 multiplication does
not occur under those conditions until ∼8 hpi (Lewis et al., 2015).
Bacterial growth is conditional on ETS accomplished by the collective
actions of the bacterial effectors, a pre-requisite being suppression of
both photosynthesis and chloroplast reactive species generation (de
Torres Zabala et al., 2015). To determine the origin of 3′-O-β-D-RFA we
compared its accumulation in uninfected leaves with leaves challenged
with DC3000hrpA (this mutant strain cannot deliver effectors to
suppress immunity and elicits a basal immune response), or virulent
DC3000 (causes foliar disease). Uninfected leaves contain very low le-
vels of 3′-O-β-D-RFA suggesting this was of plant origin (Fig. 1). No
significant accumulation of 3′-O-β-D-RFA was detected following
DC3000hrpA challenge, consistent with our hypothesis that the activity
of the 28 DC3000 effectors delivered into the plant cell (Cunnac et al.,
2011) were responsible for its accumulation. To rule out the possibility
3′-O-β-D-RFA is of bacterial origin we used a transgenic A. thaliana line
conditionally expressing the P. syringae effector HopAM1 from a dex-
amethasone inducible promoter in Wassilewskija background (Goel
et al., 2008). Conditional expression of HopAM1 increases P. syringae
virulence by enhancing pathogen induced ABA that play a key role in
suppressing plant defense responses. Leaves of a transgenic A. thaliana
Ws-0 lines conditionally expressing HopAM1 from a dexamethasone
inducible promoter showed accumulation of 3′-O-β-D-ribofur-
anosyladenosine within 12 h of dexamethasone (5 μM) application. By
contrast 3′-O-β-D-RFA did not accumulate above basal levels in wild
type A. thaliana Ws-0 (Fig. S2).
To determine whether accumulation of 3′-O-β-D-RFA is genetically
linked to DC3000 virulence we examined a broad spectrum of
Arabidopsis mutants showing enhanced resistance to DC3000. DC3000
hijacks the phytohormone ABA signalling pathway to promote viru-
lence (de Torres-Zabala et al., 2007) and the ABA biosynthetic mutant
Arabidopsis aldehyde oxidase 3 (aao3), deficient in the penultimate step
of ABA biosynthesis, is more resistant to DC3000 infection (de Torres
Zabala et al., 2009). Another phytohormone, jasmonic acid also sup-
presses plant defenses and A. thaliana mutants in the jasmonate re-
ceptor Coronatine Insensitive 1 (COI1) are more resistant to DC3000
(Brooks et al., 2005). In leaves of the aao3 or coi1 A. thaliana mutants
challenged with DC3000, 3′-O-β-D-RFA accumulated to significantly
lower levels than wild type Col-0 leaves (Fig. 2) correlating 3′-O-β-D-
RFA levels with severity of disease development. Moreover, consistent
with the prediction that adenosine is a likely precursor for 3′- O-β-D-
RFA synthesis, leaf adenosine levels were lower in DC3000 challenged
leaves which accumulate more 3′-O-β-D-RFA than either of the two
mutants (Fig. 2). The accumulation of high levels of 3′-O-β-D-RFA in
infected leaves suggests a major reconfiguration of metabolism during
pathogenesis and a heavy metabolic burden on the infected plant.
Moreover, since these mutants affected quite distinct signalling path-
ways, these data suggest that 3′-O-β-D-RFA is a metabolite directly
Fig. 1. Dynamics of foliar 3′-O-β-D-ribofuranosyladenosine accumulation
following challenge with virulent and non-pathogenic P. syringae. Leaves
of Col-0 wild type A. thaliana plants were challenged with either the virulent P.
syringae DC3000 or the non-pathogenic DC3000hrpA mutant (OD600= 0.15)
and samples taken at the time shown. Metabolites were extracted in 10% me-
thanol, 1% acetic acid and relative levels of 3′-O-β-D-ribofuranosyladenosine
accumulation over time between the two treatments were determined. NI –
non-induced. The figure is representative of three independent experiments,
with error bars representing the standard deviation of the mean.
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associated with disease progression, rather than being associated with a
specific arm of DC3000's multifaceted virulence strategy.
2.2. Synthesis of 3′-O-β-D-ribofuranosyladenosine
To determine the biological function of 3′-O-β-D-RFA, we designed
a three step chemical synthesis strategy for 3′-O-β-D-ribofur-
anosyladenosine (Fig. 3). First we developed a general route for the
preparation of 2ʹ-O-β-D-ribofuranosylnucleosides by condensation of N-
acyl-3ʹ,5ʹ-O-(tetra-isopropyldisiloxane-1,3-diyl)-ribonucleosides with a
slight excess of 1-O-acetyl-2,3,5-three-O-benzoyl-β-ribofuranose in the
presence of tin tetrachloride in 1,2-dichloroethane at 0 °C (Mikhailov
et al., 1995, 1997, 2005; Rodionov et al., 2000) O-Glycosylation pro-
ceeded stereospecifically with formation of a β-glycosidic bond. This
method was used for the preparation of pyrimidine 3ʹ-O-β-D-ribofur-
anosyl-2ʹ-deoxyribonucleosides (Mikhailov et al., 1996). 5ʹ-O-β-D-ri-
bofuranosyl-2ʹ-deoxyribonucleosides and 5ʹ-O-β-D-ribofur-
anosylnucleosides (Mikhailov et al., 1998).
In our first attempt for the synthesis 3′-O-β-D-RFA we used N6-
benzoyl-2′,5′-di-O-tert-butyldimethylsilyladenosine as the glycosyl-ac-
ceptor. Unfortunately, a mixture of products was formed, probably due
to the instability of the glycosidic bonds of purine nucleosides
(Gulyaeva et al., 2004). Moreover, the product and the initial glycosyl-
acceptor had comparable chromatographic mobility and thus were
difficult to separate by chromatographic purification. Therefore, the
protected nucleoside 2′,5′-di-O-tert-butyldimethylsilyladenosine (1)
with its free amino group was chosen as a more suitable glycosyl-ac-
ceptor. Glycosylation of (1) with 1-O-acetyl-2,3,5-three-O-benzoyl-β-D-
ribofuranose (2) in the presence of tin tetrachloride was stereospecific
resulting in blocked 3′-O-β-D-ribofuranosyladenosine (3). This reaction
(Fig. 3 step i) was carried out under mild conditions (0 °C; 1,2-di-
chloroethane; 16 h) as previously described (Mikhailov et al., 1995,
1997, 2005; Rodionov et al., 2000). The resulting product, 3, was easily
purified by column chromatography and was isolated with 64% yield.
The choice of synthetic strategy, involving 2′,5′-di-O-tert-butyldi-
methylsilyladenosine (1) (Ogilvie et al., 1978) as a glycosyl-acceptor, is
also associated with higher stability of the silyl protecting group to the
migration in the 2′,3′-cis-diol nucleosidic system under glycosylation
conditions compared to acyl groups.
We performed desilylation of nucleoside 3 in the presence of tet-
rabutylammonium fluoride trihydrate (Fig. 3, step ii). Partial de-
benzoylation also took place as a by-process due to the basic character
of the fluoride ion. Therefore, the resulting 9-[3-O-(2,3,5-three-O-ben-
zoyl-β-D-ribofuranosyl)-β-D-ribofuranosyl]adenine (4) was isolated
with 55% yield. Debenzoylation of nucleoside 4 was performed in
methanolic ammonia. The final product, 3′-O-β-D-ribofur-
anosyladenosine (5) was purified by crystallization from water (Fig. 3
step iii) with 65% yield resulting in an overall yield of 23%.
While the majority of the known disaccharide nucleosides demon-
strate high solubility in water because of the presence of two hydro-
philic carbohydrate moieties in their structure, interestingly compound
5, bearing five hydroxyl groups and one amino-group, had low solu-
bility in both water and organic solvents.
The 1H-NMR spectrum of the synthesized compound 5 was identical
in all respects to the spectrum of 3′-O-β-D-RFA, isolated from natural
sources (Table 1; See also Supplementary Data, Figs. S3–S19). The
presence of the (1'→3′)-glycosidic bond was confirmed by hetero-
nuclear multiple bond correlation (HMBC) NMR. In HMBC, the spectra
of compounds 4 and 5, the cross-peaks between H-1' (Rib) and С-3'
(Ado) and between H-3' (Ado) and C-1' (Rib) are present (Figs. S10 and
S17). The coupling constant for trans-orientated protons H-1' (Rib) and
H-2' (Rib) in extra ribose residue is J1′,2' < 0.5 Hz, that is characteristic
for β-configuration of glycosidic bond in disaccharide nucleosides
(Mikhailov et al., 1996, 1997). UV-spectrum of 3′-O-β-D-RFA in H2O is
characterized by absorption maximum at 259 nm (ε ∼14900) at рН
7–13 with slightly hypsochromic shift under acidic conditions (Fig.
Fig. 2. 3′-O-β-D-ribofuranosyladenosine appears to be derived from ade-
nosine and accumulation is related to host susceptibility to P. syringae
DC3000. Both the ABA biosynthetic mutant aao3, that prevents pathogen ac-
cumulation of the immunosuppressor ABA and the jasmonate receptor mutant
coi1 are more resistant to DC3000. Both mutants exhibit higher levels of foliar
adenosine and much reduced levels of 3′-O-β-D-ribofuranosyladenosine com-
pared to susceptible wild type Col-0 following challenge with DC3000
(OD600= 0.15) sampled 18 hpi. Error bars represent the standard deviation of
the mean. This experiment was repeated twice.
Fig. 3. Synthesis of 3′-O-β-D-ribofuranosyladenosine. A three step proce-
dure was developed in which; (i) The nucleoside 2′,5′-di-O-tert-butyldi-
methylsilyladenosine (1) was glycosylated with 1-O-acetyl-2,3,5-three-O-ben-
zoyl-β-D-ribofuranose (2) in the presence of tin tetrachloride SnCl4/1,2-
dichloroethane at 0 °C for 16 h generating blocked 3′-O-β-D-ribofuranosyl
adenosine (∼64% efficiency); (ii) This was desilylated and partially de-
benzoylated in the presence of tetrabutylammonium fluoride trihydrate for
45min, yielding 9-[3-O-(2,3,5-three-O-benzoyl-β-D-ribofuranosyl)-β-D-ribofur-
anosyl]adenine (4) at ∼55%; and finally (iii) 4 was debenzoylated in metha-
nolic ammonia to yield 3′-O-β-D-ribofuranosyladenosine (5) at ∼65% effi-
ciency and this was subsequently purified by crystallization from water.
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S19), which is typical for adenosine derivatives (Albert, 1973; Dowson
et al., 1986).
2.3. Assessing the biological activity of 3′-O-β-D-ribofuranosyladenosine
Following synthesis, we first determined the extent of accumulation
of 3′-O-β-D-RFA following DC3000 infection. Fig. 4 shows that 3′-O-β-
D-RFA represents ∼1/2000th of the dry weight of an infected leaf 22 h
after infection with DC3000 (OD600 0.15). We next tested the impact of
3′-O-β-D-RFA on the infection process.
Based on an average leaf DW of 2.4mg (Browse and Somerville,
1994), 3′-O-β-D-RFA levels were estimated to be ∼1.5 μg per leaf 22 h
post infection. Therefore we either pre-infiltrated (16 h before infec-
tion) or co-infiltrated DC3000 with two synthetic 3′-O-β-D-RFA con-
centrations (50 μg/ml or 100 μg/ml) corresponding to delivery of 2 μg
or 4 μg of 3′-O-β-D-RFA/leaf based upon a conservative average of
40μl/leaf of inoculum. Neither treatments resulted in any significant
differences in bacterial growth (data not shown). Similarly, supple-
mentation of 3′-O-β-D-RFA to Kings B plates (25 μg/ml) had neither a
positive nor negative affect on DC3000 multiplication (data not shown).
This lack of demonstrable biological activity associated with 3′-O-β-D-
RFA, i.e. neither suppression or enhancement of immunity following co-
infiltration, or alternatively, restriction or enhancement of DC3000
growth in vitro, was surprising given the remarkable rapid infection
dynamics of this novel molecule following DC3000 inoculation. While
we can rule out an antimicrobial effect of 3′-O-β-D-RFA on P. syringae,
we cannot determine from the in vivo studies that apoplastically3′-O-β-
D-RFA delivered into the apoplast was taken up into the plant cells. An
alternative possibility to consider is that 3′-O-β-D-RFA is actually an
artefact of the extraction procedure and a highly related compound is
actually the biologically active species formed by DC3000 infection.
Future work will explore these possibilities.
3. Discussion
In summary, we comprehensively demonstrate the dynamics of
plant derived 3′-O-β-D-RFA accumulation during susceptible interac-
tions and present a detailed synthesis strategy, supported by NMR va-
lidation. It was unambiguously demonstrated that our synthetic 3′-O-β-
D-RFA has the same chromatographic mobility with the cognate me-
tabolite rapidly induced in DC3000 infected leaves. However, in the
absence of any detectable biological activity on bacterial disease pro-
gression or host defense processes we hypothesise that 3′-O-β-D-RFA
may represent a degradation product of a highly labile disaccharide
nucleoside that is modified under our extraction conditions.
Alternatively 3′-O-β-D-RFA's sole role may be to deplete the plant pool
of pyridine nucleotides and suppress one arm of the plant immune re-
sponse. Regardless, accumulation of a disaccharide nucleoside to such
levels suggests major metabolic re-programming and is likely to have a
significant impact on the plants metabolic status and warrants further
investigation.
Mono ADP-ribosyltransferases cleave NAD+ and covalently attach
the ADP-ribosyl moiety to target proteins, or DNA/RNA (Hassa et al.,
2006). DC3000 has at least 4 predicted mono ADP-ribosyltransferases
(Hop-U1, Hop-F2, HopO1-1, HopO1-2) that are annotated as effectors
(Block and Alfano, 2011; Lindeberg et al., 2012) and could modify host
proteins, DNA/RNA or, as we hypothesise here, small molecules leading
to the generation of 3′-O-β-D-RFA. This raises the question as to what
the 3′-O-β-D-RFA substrate(s) may be. The pyridine nucleotides NAD+
and NADP + play vital roles in metabolic reactions, as signal molecules
themselves or via their derivatives and in plants are being increasingly
linked to plant immune processes (Miwa et al., 2017). Given the well-
established role of reactive oxygen generation in plant innate immunity
(both PTI and ETI), one possibility is that plant pathogens may deploy
strategies to reduce the pool of pyridine nucleotides to suppress plant
defense responses. We recently showed that in A. thaliana leaves fol-
lowing DC3000 infection and prior to bacterial growth, photosynthesis
is inhibited and chloroplastic ROS is suppressed (de Torres Zabala et al.,
2015). Inhibition of photosynthesis would lead to the accumulation of
NADP+ and one could envisage a mechanism would be needed to
scavenge this NADP+. To address these concepts we speculated on a
possible biosynthetic route for 3′-O-β-D-RFA (Fig. S20), either from
AMP or NAD+ via activities of NUDIX hydrolase and phosphoribosyl/
glycosyl transferases and subsequent phosphate removal, using an ex-
ample of candidate gene expression profiles derived from published
microarray data (Thilmony et al., 2006) to support our model. 3′-O-β-D-
RFA's structure implicates NAD+ or NAADP may serve as a substrate
not only for ADP-ribosylation reactions but also to generate precursors
of the calcium mobilizing molecule cADPr (cyclic ADP-ribose). Alter-
natively 3′-O-β-D-RFA may function to dampen the pool of reducing
equivalents which are essential to counteract oxidative damage and for
other detoxifying reactions during host defense responses.
4. Experimental
4.1. Arabidopsis thaliana growth
Brassicaceae A. thaliana genotypes were sown in a 6:1 compost mix
of Levingtons F2 compost with sand (LEV206): vermiculite (medium
grade). Plants were grown under short days at 65% humidity in a
controlled environment chamber (10 h light, 120 μE at 22 °C day, 20 °C
Table 1
1H-NMR data for compound 5 in CD3OD.
Nucleoside: Chemically synthesizeda Isolated from natural sourcesb
Fragment Adoc β-Ribc Adoc β-Ribc
H-1' (J1′, 2′) 6.00 d (4.3) 5.07 s (< 0.5) 6.00 d (4.3) 5.05 s (< 0.5)
H-2' (J2′, 3′) 4.71 dd (5.2) 4.06 d (4.7) 4.70 dd (5.1) 4.04 d (4.5)
H-3' (J3′, 4′) 4.43 t (5.1) 4.37 dd (7.2) 4.43 t (5.1) 4.37 dd (7.2)
H-4' (J4′, 5′a) 4.23 ddd (2.4) 4.00 ddd (2.5) 4.21 ddd (2.3) 3.98 ddd (2.3)








H-5′b (J4′, 5′b) 3.76 dd (2.8) 3.68 dd (3.1) 3.77 dd (2.8) 3.67 dd (3.1)
H-8 8.35 s 8.40 s
H-2 8.20 s 8.21 s
a NMR spectrum was obtained at 400MHz.
b NMR spectrum was obtained at 500MHz (Bednarek et al., 2004).
c s: singlet, d: doublet, dd: doublet of doublet, ddd: doublet of doublet of
doublet, t: triplet.
Fig. 4. Quantitation of 3′-O-β-D-ribofuranosyladenosine during P. syringae
disease development. Synthetic 3′-O-β-D-ribofuranosyladenosine standard
was used to quantify pathogen induced 3′-O-β-D-RFA accumulation in leaves
following challenge with DC3000 (OD600 0.15). Error bars representing stan-
dard deviation of the mean. All experiments were repeated at least three times.
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night) for 4–5 weeks before use. Arabidopsis genotypes studied in this
work were Col-0, aao3 (de Torres Zabala et al., 2009) coi1-16 (Ellis and
Turner, 2002) and myc2 (Lorenzo et al., 2004).
Dexamethasone inducible HopAM1 lines in the Wassilewskija
background (Goel et al., 2008) were treated with 5 μM of freshly pre-
pared Dexamethasone (Sigma) and leaves harvested into liquid ni-
trogen at the appropriate timepoint.
4.2. Pseudomonas syringae infections
Bacterial cultures of the virulent Pseudomonadaceae Pseudomonas
syringae pv. tomato strain DC3000 were maintained, prepared and in-
oculated in Kings B medium as described (de Torres et al., 2006). For
metabolite extractions and growth curves (following 3′-O-β-D-RFA pre-
treatment and co-infiltration), A. thaliana leaves were inoculated with a
1-ml needleless syringe on their abaxial surface with a bacterial sus-
pension adjusted with 10mM MgCl2 to a final density OD600 0.15
(∼0.75× 108 colony forming units (cfu) ml−1) to measure 3′-O-β-D-
RFA accumulation or OD600 0.0002 to test impact of 3′-O-β-D-RFA pre-
treatment (16 h pre-infiltration) and co-infiltration on bacterial growth.
All bacterial growth measurements were determined from a minimum
of 5 independent replicates, each comprising three challenged leaves/
plant.
4.3. 3′-O-β-D-ribofuranosyladenosine measurements
3'-O-β-D-RFA was measured by a modification of the method of
(Forcat et al., 2008). Three-four leaves of fully developed leaves of 4–5
week old wild type Arabidopsis thaliana Col-0 or specific homozygous
mutant lines (aao3, coi1 or myc2) were challenged as described. Each
replicate comprised of 6–8 leaves from 2 plants and three biological
replicates per experiment were harvested at the specified specific time.
Leaves were snap frozen in liquid nitrogen then freeze dried. 10mg of
freeze dried leaf powder was extracted with 400 μl ice cold extraction
buffer (10% methanol, 0.1% acetic acid), containing unlabelled um-
billiferone (Sigma, UK) as an internal standard (14.4 μg/sample).
Samples were left on ice for 30min with vortexing, then sonicated in an
ice bath for 10min. After centrifugation (10min at 16,100×g, 4 °C), the
pellet was re-extracted in 400 μl ice cold extraction buffer (without
internal standard) and both supernatants pooled, then filtered through
a 0.2 μm (PVDF) syringe filter (Chromacol, Welwyn Garden City, UK).
3′-O-β-D-RFA quantitative analysis was performed using an Agilent
6420B triple quadrupole (QQQ) mass spectrometer (Technologies, Palo
Alto, USA) coupled to a 1200 series Rapid Resolution HPLC system.
10 μl of sample extract were loaded onto a Zorbax Eclipse Plus C18
(3.5 μm, 2.1 mm×100mm) reverse phase analytical column (Agilent
Technologies, Palo Alto, USA). Samples were loaded in buffer A (1mM
ammonium fluoride, 5% acetonitrile) and separated at a flow rate of 0.3
ml/min−1 using Buffer B (95% acetonitrile) by one of two gradient
protocols; t= 0 (5% B); t= 6min (100% B); t= 8min (100% B),
t= 8.5min (5% B) t= 12min (5% B) or t= 0 (0% B); t= 5min (20%
B); t= 20min (100% B); t= 25min (100% B); t= 27min (0% B).
Samples were detected in positive mode using the following tran-
sitions: 3′-O-β-D-RFA; 400 > 136 and 400 > 268; Umbelliferone;
163 > 107 and adenosine 268 > 136. The QQQ source conditions
were as follows: gas temperature 350 °C, drying gas flow rate 9 l min-1,
nebuliser pressure 35 psig, capillary voltage±4 kV. For all samples the
dwell time of 50, a fragmentor voltage of 90 and a collision energy of
20 V were used. Significance differences between treatments were de-
termined by Students t-test (p < 0.5), error bars representing standard
deviation of the mean. All experiments were repeated at least three
times.
4.4. 3′-O-β-D-ribofuranosyladenosine synthesis
Solvents and materials of reagent grade were used without
additional purification. Column chromatography was performed on si-
lica gel (Kieselgel 60, Merck, 0.040–0.063mm) using EtOHeCH2Cl2 as
eluent system. TLC was performed on TLC silica gel 60 F254 (Merck)
with UV visualization. Melting points were determined on an
Electrothermal apparatus and are uncorrected. 1H and 13C (with com-
plete proton decoupling) NMR spectra were recorded on Bruker AMX
400 NMR and Bruker AVANCE II 300 instruments at 305 K. NMR
spectra of compound 5 in D2O were recorded at elevated temperature
(328 K) because of its low solubility in both water and organic solvents.
Chemical shifts, δ, are given in ppm and measured relative to solvent
signals (CDCl3, 1H: δ=7.26, 13C: δ= 77.16; DMSO‑d6 1H: δ=2.50;
CD3OD, 1H: δ=3.31, 13C: δ= 49.00, D2O, 1H: δ= 4.79). Coupling
constants, J, are given in hertz (Hz). Double resonance technique was
applied to assign the resonances. UV-spectra were recorded on a
Cary300 UV/VIS spectrophotometer (Varian). LC-MS analysis was
performed on Surveyor MSQ instrument (Thermo Finnigan, USA), op-
erating in APCI mode with detection of positive and negative ions, and
equipped with an Onyx Monolithic C18 25× 4.6mm Part No CHO-
7645 column; eluent: 0.1% HCOOHeH2O gradient in MeCN.
Chromatographic peaks were detected simultaneously with ELSD, PAD
and TIC detectors. 1-O-Acetyl-2,3,5-three-O-benzoyl-β-D-ribofuranose
(2) was purchased from Pfanstiehl Laboratories Inc. (USA).
4.4.1. Preparation of 2′,5′-di-O-tert-butyldimethylsilyladenosine (1)
2′,5′-Di-O-tert-butyldimethylsilyladenosine (1) was prepared ac-
cording to the literature (Ogilvie et al., 1978). Rf 0.44 (toluene:ethyl
acetate – 1:4). 1H-NMR (DMSO‑d6): 8.27 s (1H, H-8), 8.13 (1H, H-2),
7.26 s (2H, NH2-Ade), 5.94 s (1H, J1′,2’=5.2, H-1′), 5.07 d (1H, J3′,3′
-OH=5.6, 3′-OH), 4.63 dd (1H, J2′,3’=5.1, H-2′), 4.15 ddd (1H,
J3′,4’=3.4, H-3′), 4.01 td (1H, J4′,5‘a= J4′,5′ b=3.8, H-4′), 3.93 dd (1H,
J5′a,5‘b=- 11.4, H-5′a), 3.79 dd (1H, H-5′b), 0.90 s (9H, Me3C), 0.75 s
(9H, Me3C), 0.08 s (3H, Me), 0.07 s (3H, Me), −0.06 s (3H, Me),
−0.16 s (3H, Me). 13C-NMR (CDCl3): 155.33 (C-2), 152.60 (C-6),
150.06 (C-4), 139.29 (C-8), 119.93 (C-5), 88.24 (C-1′), 85.41 (C-4′),
71.34 (C-3′), 63.24 (C-5′), 26.17(Me3C), 25.73 (Me3C), 18.62, 18.08
(Me), −4.85, −5.15, −5.19, −5.31 (Me).
4.4.2. Preparation of 9-[2,5-di-O-(tert-butyldimethylsilyl)-3-O-(2,3,5-
three-O-benzoyl-β-D-ribofuranosyl)-β-D-ribofuranosyl]adenine (3)
To a cold solution (0°С) of 1-O-acetyl - 2,3,5-three-O-benzoyl-β-D-
ribofuranose (2) (1.068 g, 2.12mmol) in 1,2-dichloroethane (15ml)
under nitrogen tin tetrachloride (0.44ml, 3.8 mmol) was added and the
solution was kept at 0°С for 5 h. After addition of nucleoside 1 (700mg,
1.4 mmol) the resulting solution was kept at 0°С for 16 h. Then 10%
aqueous solution of sodium bicarbonate (50ml) was added and the
suspension was stirred at 0°С for 20min. The suspension was diluted
with methylene chloride (30ml), filtered through Hyflo Super Cel, the
organic layer was separated, washed with water (10ml), dried over
sodium sulfate and evaporated to dryness. The residue was purified by
column chromatography on silica gel (50 g). The column was washed
with methylene chloride (500ml), and then eluted with 1% ethanol in
methylene chloride to give 3 as a foam. Yield 842mg (64%). Rf 0.31
(methylene chloride:ethanol – 98:2). 1H-NMR (CDCl3): 8.33 s (1H, H-8),
8.30 s (1H, H-2), 7.99 dd (2H, Jo-H, m-H= 8.3, Jo-H, p-H= 1.1, Bz), 7.95
dd (2H, Jo-H, m-H= 8.4, Jo-H, p-H= 1.2, Bz), 7.91 dd (2H, Jo-H, m-H= 8.2,
JoH, p-H= 1.2, Bz), 7.58 tt (1H, Jp-H, m-H= 6.1, Jp-H, o-H= 1.2, Bz),
7.55–7.48m (2H, Bz), 7.42 dd (2H, Jm-H, o-H= 8.2, Jm-H, p-H= 6.1, Bz),
7.38–7.30m (4H, Bz), 6.34 br.s (2H, NH2-Ade), 6.06 d (1H, J1′,2’=3.4,
H-1′ Ado), 5.75 dd (1H, J3′,2’=5.1, J3′,4’=6.4, H-3′ Rib), 5.64 dd (1H,
J2′,1’=1.4, H-2′ Rib), 5.45 d (1H, H-1′ Rib), 4.77 dd (1H, J2′,3’=4.0, H-
2′ Ado), 4.72–4.61m (2H, H-3′ Ado, H-4′ Rib), 4.60–4.52m (2H, H-5′a,
H-5′b Rib), 4.38 ddd (1H, J4′,3’=5.4, J4′,5′a= 3.1, J4′,5‘b= 2.6, H-4′
Ado), 4.12 dd (1H, J5′ a,5‘b=−11.8, H-5′a Ado), 3.90 dd (1H, H-5′b
Ado), 0.91 s (9H, Me3C), 0.89 s (9H, Me3C), 0.13 s (3H, Me), 0.11 s (3H,
Me), 0.09 s (3H, Me), 0.00 s (3H, Me). 13C-NMR (CDCl3): 166.18,
165.40, 165.37 (C]O), 155.54 (C-2), 153.15 (C-6), 149.95 (C-4),
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139.31 (C-8), 133.55, 133.22, 129.91, 129.88, 128.62, 128.50, 128.46
(Bz), 120.29 (C-5), 104.66 (C-1′ Rib), 89.16 (C-1′ Ado), 82.08 (C-4′
Ado), 79.17 (C-3′ Ado), 75.65 (C-4′ Rib), 75.57 (C-2′ Rib), 75.33 (C-2′
Ado), 72.50 (C-3′ Rib), 65.63 (C-5′ Rib), 62.33 (C-5′ Ado), 26.09, 25.78
(SiMe2t-Bu), 18.50, 18.17 (CMe3), −4.66, −4.79, −5.23, −5.39
(CMe3).
4.4.3. Preparation of 9-[3-O-(2,3,5-three-O-benzoyl-β-D-ribofuranosyl)-β-
D-ribofuranosyl]adenine (4)
Nucleoside 3 (750mg, 0.8 mmol) was dissolved in 0.5M tetra-
butylammonium fluoride trihydrate in tetrahydrofuran (2.2 ml). The
solution was kept for 1 h at 20°С, evaporated to dryness, coevaporated
with chloroform (2×15ml) and applied onto silica gel column (20 g).
The column was washed with methylene chloride (300ml) and with 2%
ethanol in methylene chloride (200ml) and then eluted with 3.5%
ethanol in methylene chloride to give 4 as a foam. Yield 313mg (55%).
Rf 0.41 (methylene chloride:ethanol – 95:5). 1H-NMR (CDCl3): 8.15 s
(1H, H-2), 8.07 d (2H, Jo-H, m-H= 7.4, Bz), 7.99 d (2H, Jo-H, m-H= 7.4,
Bz), 7.91 d (2H, Jo-H, m-H= 7.6, Bz), 7.70 s (H-8), 7.57 t (2H, Jm-H, o-
H= Jm-H, p-H= 7.4, Bz), 7.54–7.49m (1H, Bz), 7.41 t (4H, Jm-H, o-
H= Jm-H,-p-H= 7.6, Bz), 7.34 t (2H, Jp-H, m-H= 7.6, Bz), 6.52 br.s (2H,
NH2 Ade), 5.92 dd (1H, J3′,2’=4.7, J3′,4’=6.3, H-3′ Rib), 5.80 d (1H,
H-2′ Rib), 5.74 d (1H, J1′,2’=7.2, H-1′ Ado), 5.51 s (1H, H-1′ Rib), 5.05
dd (1H, J2′,3’=4.8, H-2′ Ado), 4.85–4.71m (3H, H-4′ Rib, H-5′a, H-5′b
Rib), 4.66 d (1H, H-3′ Ado), 4.37 s (1H, H-4′ Ado), 3.97 d (1H, J5′
a,5′b=−12.8, H-5′a Ado), 3.76 d (1H, H-5′b Ado). 13C-NMR (CDCl3):
166.50, 165.54, 165.43 (C]O), 155.58 (C-2), 151.75 (C-6), 148.45 (C-
4), 141.10 (C-8), 133.82, 133.72, 133.60, 129.94, 129.90, 128.69,
128.58 (Bz), 120.85 (C-5), 106.36 (C-1′ Rib), 91.25 (C-1′ Ado), 85.88
(C-4′ Ado), 80.72 (C-3′ Ado), 80.05 (C-4′ Rib), 75.90 (C-2′ Rib), 73.54
(C-2′ Ado), 72.08 (C-3′ Rib), 64.83 (C-5′ Rib), 63.02 (C-5′ Ado). LC-MS
(APCI): retention time - 2.35min; m/z (rel. int): [M+H]+ 712.59
(100).
4.4.4. Preparation of 9-[3-О-β-D-ribofuranosyl-β-D- ribofuranosyl]adenine
(5)
A solution of nucleoside 4 (300mg, 0.421mmol) in 5M ammonia in
methanol (16ml) was kept for 5 days at 20°С and then concentrated in
vacuo to dryness. The residue was partitioned between chloroform
(10ml) and water. The aqueous layer was washed with chloroform
(4× 15ml). The aqueous layer was evaporated to the volume ∼2ml
and was left to stay overnight at 0°С. The precipitate was filtered,
washed with acetone (2×5ml) and dried in vacuum desiccator over
phosphorus pentoxide. Yield 110mg (65%) as a white powder. M.p.
232–234°С (dec.). Rf 0.075 (methylene chloride:ethanol – 80:20). UV
(H2O): λmax, nm (ε, M−1cm−1): 259 (14900) (pH 7–13), 257 (14500)
(pH 2). 1H-NMR (D2O): 8.39 s (1H, H-2), 8.30 s (1H, H-2), 6.14 d (1H,
J1′,2’=5.0, H-1′ Ado), 5.28 s (1H, H-1′ Rib), 4.91 dd (1H, J2′,3’=4.9,
H-2′ Ado), 4.58 dd (1H, J3′,4’=4.8, H-3′ Ado), 4.49–4.42m (2H, H-3′
Rib, H-4′ Ado), 4.29 d (1H, J2′,3’=4.7, H-2′ Rib), 4.20–4.14m (1H, H-
4′ Rib), 4.03 dd (1H, J5′ a,4’=2.8, J5′ a,5′b=−12.9, H-5′a Rib), 3.95 dd
(1H, J5′ a,4’=2.6, J5′ a,5′b=−12.5, H-5′a Ado), 3.91 dd (1H, J5′
b,4’=3.6, H-5′b Rib), 3.82 dd (1H, J5′ b,4’=5.1, H-5′b Ado). 13C-NMR
(D2O, 323 K): 155.92 (C-8), 143.57 (C-2), 123.00 (C-5), 110.01 (C-1′
Rib), 91.65 (C-1′ Ado), 86.40, 86.27 (C-4′ Ado, C-4′ Rib), 79.72 (C-3′
Ado), 77.90 (C-2′ Rib), 76.33 (C-2′ Ado), 73.11 (C-3′ Rib), 64.57, 64.25
(C-5′ Ado, C-5′ Rib). LC-MS (APCI): retention time – 0.44min; m/z (rel.
int): [M+H]+ 400.28 (100).
5. Conclusion
We characterize the dynamics of accumulation of the natural dis-
accharide nucleoside, 3′-O-β-D-ribofuranosyladenosine, in Arabidopsis
thaliana leaves infected with virulent DC3000 and show it is a plant
specific molecule and its increase is directly correlated to bacterial
multiplication. We provide a detailed method for the synthesis of 3′-O-
β-D-ribofuranosyladenosine and its detailed characterization. While
this allowed the quantification of the accumulation of 3′-O-β-D-ribo-
furanosyladenosine in infected leaves, including its exponential in-
crease during the latter stages of infection. We speculate a role for 3′-O-
β-D-ribofuranosyladenosine in altering the hosts pool of pyridine nu-
cleotides to suppress plant defense responses. However, we were unable
to demonstrate any biological activity - either in modulating bacterial
growth or modifying bacterial load in infected leaves. Future work will
explore the possibility whether 3′-O-β-D-ribofuranosyladenosine deri-
vatives are biologically active compounds, or 3′-O-β-D-ribofur-
anosyladenosine's key role is to deplete the plant pool of pyridine nu-
cleotides.
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